Clinical trials
Phase 4 Ventricular Dysfunction, Left trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Boston University | 1 |
| GE Healthcare | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Jewish General Hospital | 1 |
| Kafrelsheikh University | 1 |
| Kyungsub Song | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ventricular Dysfunction, Left | 19 |
| Heart Failure | 5 |
| Hypertension | 2 |
| Iron Deficiencies | 2 |
| Metabolic Syndrome | 2 |
| Ventricular Dysfunction | 2 |
| Ventricular Dysfunction, Right | 2 |
| Anemia, Iron-Deficiency | 1 |
| Erectile Dysfunction | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.